DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue S 1 · Volume 113 · 2005 DOI: 10.1055/s-002-3872


9th Annual Meeting of the Neuroendocrinology Section of the German Society of Endocrinology (DGE)
Münster, 9th –12th March 2005

Prof. Dr. L. Kiesel, Münster
Abstracts (HTML) List of Authors
1
Vierhapper, H.; Nowotny, P.; Waldhäusl, W.: Production rates of cortisol in obesity determined by stable isotope dilution/mass spectrometry
2
Roth, C.; Brezinski, S.; Harz, K.; Woelfle, J.; Ludwig, M.: Investigations of melanocortin-receptor genes in patients with severe childhood obesity
3
Burget, L.; Castaeda, T.; Strasburger, C. J.; Tschöp, M.; Bidlingmaier, M.: Brain specific growth hormone receptor blockade modulates feeding in rats
4
Wellhöner, P.; Welzel, M.; Rolle, D.; Fehm, H. L.; Dodt, C.: Metabolic effects of intravenous corticotropin releasing hormone on adipose tissue metabolism in humans
5
Böttner, A.; Kratzsch, J.; Seidel, B.; Wabitsch, M.; Kiess, W.: Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components
6
Petersenn, S.; Wallner, B.; Range, I. M.; Tourne, H.; Unger, N.; Mann, K.: Physiological regulation of ghrelin by nutrient load in lean and obese subjects
7
Weickert, M. O.; Möhlig, M.; Koebnick, C.; Osterhoff, M. A.; Ristow, M.; Rochlitz, H.; Rudovich, N.; Spranger, J.; Pfeiffer, A. F. H.: Beneficial effects of dietary wheat and oat fibre are independent of colonic fermentation
8
Kralisch, S.; Fasshauer, M.; Paschke, R.; Kahn, C. R.; Blüher, M.: Depot-specific differences in adipocyte biology and adipose tissue gene expression – parallel regulation in humans and mice
9
Lamounier-Zepter, V.; Rotthoff, T.; Scherbaum, W. A.; Bornstein, S. R.; Ehrhart-Bornstein, M.: Increased aldosterone/renin ratio in obese hypertensive women
10
Harsch, I. A.; Wallaschofski, H.; Koebnick, C.; Pour Schahin, S.; Lohmann, T.: Adiponectin in obese patients with obstructive sleep apnoea syndrome
11
Bojunga, J.; Welsch, C.; Albrecht, M.; Antes, I.; Lengauer, T.; Zeuzem, S.: Computer modeling of the 3D structure of human cytochrome P450c21 in a young woman with late-onset AGS and a new mutation within the steroid-21-hydroxylase gene
12
Eicke, N.; Günthert, A. R.; Siebold, D.; Béhé, M.; Becker, T.; Emons, G.; Gründker, C.: GnRH-II receptor-like antigenicity in human endometrial, ovarian and breast cancer cells
13
Schams, D.; Welter, H.; Berisha, B.: The expression of MMP family members in bovine follicles before and after LH surge and in luteal tissue
14
Wolf, O. T.; Heinrich, A. B.; Hanstein, B.; Djahansouzi, S.; Kirschbaum, C.: Free cortisol levels in older hysterectomized women treated with estradiol or estradiol/progesterone: Results from a randomised placebo controlled double-blind study
15
Riese, C.; Streckfuss, F.; Schweizer, U.; Köhrle, J.; Schomburg, L.: Gender-specific differences in the expression of selenoproteins in mammals
16
Berisha, B.; Miyamoto, A.; Schams, D.: The expression of angiopoietin-tie system members in CL during oestrous cycle and induced luteolysis in cow
17
Rose, M.; Schoof, B.; Klapp, B. F.; Ventz, M.: Sexuality, body image and quality of life in patients with 21-hydroxylase deficiency
18
Pocar, P.; Nestler, D.; Risch, M.; Fischer, B.: Arylhydrocarbon receptor (AhR) activity during in vitro oocyte maturation (IVM)
19
Briese, J.; Oberndörfer, M.; Kelp, B.; Schulte, H. M.; Löning, T.; Bamberger, A. M.: Expression pattern of osteopontin (OPN) in the human placenta – correlation with expression of the adhesion molecule CEACAM1
20
Kleine, B.; Wagner, S.; Rahm, K.; Rossmanith, W. G.: Gene expression differences between placentae from normal healthy and diabetic, growth retarded or pre-eclamptic pregnancies
21
Groß, U. S.; Epe, M.; Drexler, H. H. S.; Schulte, H. M.: Identification of a novel mutation in MODY3 (TCF1 gene) in differential diagnosis of diabetes mellitus
22
Schnell, S.; Leitges, M.; Schöfl, C.: Acetylcholine-induced calcium signaling in pancreatic beta-cells derived from protein kinase C epsilon deficient mice
23
Manfras, B. J.; Hengster, P.; Böhm, B. O.: Glucose regulation of secretory and metabolic pathway genes in human pancreatic islets
24
Kutschenko, A.; Oetjen, E.; Knepel, W.: Reactive oxygen species inhibit calcineurin phosphatase activity in a pancreatic islet beta cell line
25
Hensen, J.; Müller-Ziehm, J.; Worthmann, W.: Hospital related hyperglycemia and diabetes mellitus in the intensive care unit (ICU) – two “down-to-earth“ protocols
26
Schladitz, A.; Pittasch, D.; Lehnert, H.; Lobmann, R.: Prevalence of peripheral autonomic neuropathy in patients with diabetes
27
Blüher, M.; Wallaschofski, H.: Prolactin an diabetogenic hormone?
28
Bullmann, C.; Verheyen, F.; Köppel, D.; Walkenhorst, K.: Assessing the benefits of disease management programs
29
Schrader, J.; Jahr, H.; Brendel, M.; Burks, D.; Hörsch, D.: Limited expansion and improved survival of primary human beta-cells by adenoviral overexpression adaptorprotein IRS-2 and cell cycle regulating kinase cdk-4
30
Schneider, S.; Klein, H. H.: Long-term graft function of adult rat islets after transplantation in immunocompetent diabetic mice treated with donor specific splenocytes and anti-CD154 monoclonal antibody
31
Schneider, H. J.; Schneider, M.; von Rosen, F.; Uhr, M.; Saller, B.; Stalla, G. K.: Assessment of pituitary function 3 and 12 months after traumatic brain injury: a prospective study
32
Plöckinger, U.; Krüger, D.; Bergk, A.; Berg, T.; Wiedenmann, B.: Pegylated interferon-α augments basal and stimulated GH and PRL secretion during long-term therapy in patients with chronic hepatitis C
33
Schüssler, P.; Uhr, M.; Ising, M.; Weikel, J.; Schmid, D.; Held, K.; Mathias, S.; Steiger, A.: Effects of sleep deprivation on ghrelin, ACTH, GH and cortisol secretion in normal controls
34
Kahaly, G. J.; Egle, U. T.; Bartenstein, P.; Dittmar, M.; Drecker, S.; Weber, M.; Schreckenberger, M.: Positron emission tomography (PET) study on the neuronal correlates of hyperthyroidism- associated mood changes
35
Saller, B.; Schreiber, I.; Buchfelder, M.; Droste, M.; Mann, K.; Strasburger, C. J.: Initial safety and efficacy evaluation of the German pegvisomant observational study
36
Bähr, V.; Franzen, N.; Pedersen, E. B.; Oelkers, W.; Pfeiffer, A. F.; Diederich, S.: Glucocorticoid therapy: Concentrated urine after thirsting despite pronounced suppression of vasopressin
37
Kremenevskaja, N.; Brabant, G.; Buchfelder, M.: Beta-catenin mutations are infrequent events in pituitary tumors
38
Quabbe, H. J.; Skrobek-Engel, G.; Franz, H.; Lohmann, R.: The German acromegaly register: Update and results in 400 operated patients
39
Kreutzer, J.; Eigenthaler, M.; Fahlbusch, R.; Lohmann, T.; Wallaschofski, H.: Increased risk for venous thrombembolism in patients with prolactinomas
40
Klose, S.; Reschke, K.; Lehnert, H.: Severe non-alcoholic fatty liver disease and hepatopulmonary syndrome as a rare complication of craniopharyngeoma
41
Bialek, J.; Hombach-Klonisch, S.; Weber, E.; Riedel, M.; Fiebig, B.; Holzhausen, H. J.; Dralle, H.; Hoang-Vu, C.; Klonisch, T.: Role of H2 relaxin in the human thyroid
42
Eszlinger, M.; Krohn, K.; Läuter, J.; Beck, M.; Paschke, R.: Comparison of gene expression data of hot and cold thyroid nodules and TSH stimulated primary thyroid cell cultures
43
Führer, D.; Koch, C.; Trantakis, C.; Tannapfel, A.; Paschke, R.: TSHoma with low alpha subunit in a patient with longstanding “asymptomatic“ hyperthyroidism
44
Drieschner, N.; Belge, G.; Rippe, V.; Meiboom, M.; Loeschke, S.; Bullerdiek, J.: Rearrangement of PPARγ in a thyroid adenoma without 2q13 involvement: evidence for a breakpoint hot spot within the close surrounding of PPARγ?
45
Brauer, V.; Eder, P.; Miehle, K.; Wiesner, T.; Hasenclever, D.; Paschke, R.: Interobserver variation for ultrasound determination of thyroid nodule volumes
46
Biermann, M.; Pixberg, M.; Schober, O.: Impact of treatment guidelines on radioiodine therapy for differentiated thyroid carcinoma in German-speaking Europe
47
Engelhardt, C.; Graf, D.; Herrmann, F.; Luster, M.; Reiners, C.; Quadbeck, B.; Mann, K.; Paschke, R.; Führer, D.: Prevalence of solitary hot, cold and normal functioning thyroid nodules in patients with first evaluation for a solitary thyroid nodule
48
Völzke, H.; Robinson, D.; John, U.: The association between thyroid function and gallstone disease
49
Drieschner, N.; Rippe, V.; Loeschke, S.; Focken, T.; Bullerdiek, J.; Belge, G.: Detection of chromosomal aberrations on paraffin tissue sections of benign thyroid tumours by fluorescence-in situ-hybridization (FISH)
50
Hofmann, A.; Staudenherz, A.; Vierhapper, H.; Gessl, A.: Benign and malignant thyroid tumors are more frequent in the right thyroid lobe, presumably due to its larger size
51
Gartner, W.; Weissel, M.: Do iodine containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week?
52
Brenner, N.; Gerl, H.; Biering, H.; Ventz, M.; Strasburger, C.: Ectopic adrenocorticotropin production in bilateral pheochromocytomas
53
Meyer, S.; Mach, M. A. von; Ivan, D.; Köhler, U.; Brück, C.; Wirkus, B.; Kann, P. H.: Perfusion pattern of adrenal and paraadrenal tumors visualized by endoscopic color-coded duplex sonography: an additional diagnostic tool for detecting pheochromocytomas
54
Hahner, S.; Cochran, S.; Schirbel, A.; Zink, M.; Fassnacht, M.; Allolio, B.: Potent adrenostatic activity of etomidate derivatives developed for adrenal imaging
55
Wudy, S. A.; Wachter, U.; Hartmann, M. F.; Remer, T.: At the frontier of corticosteroid metabolism: urinary cortoic acids represent a smaller fraction of oxidative cortisol metabolites than so far assumed
56
Diederich, S.; Dassler, S.; Mai, K.; Pfeiffer, A.; Perschel, F. H.: The McKenna paradigm revisited in 2004: Fully automated chemiluminescence assays for plasma aldosterone and renin allow the fast and exact classification of all disorders of the renin-angiotensin-aldosterone system
57
Weismann, D.; Fassnacht, M.; Weinberger, F.; Rothmund, M.; Hamelmann, W.; Dralle, H.; Reincke, M.; Hahner, S.; Allolio, B.: Perioperative hemodynamic stability in patients with pheochromocytoma – laparoscopic vs. open surgery
58
To, T. T.; Hahner, S.; Rohr, K.; Nica, G.; Winkler, C.; Hammerschmidt, M.; Allolio, B.: Early interrenal (adrenal) development is independent of pituitary function in the zebrafish
59
Ivan, D.; Meyer, S.; Köhler, U.; Wirkus, B.; Brück, C. C.; Kann, P. H.: Endosonographic imaging in primary hyperaldosteronism
60
Miehle, K.; Kratzsch, J.; Lenders, J.; Kluge, R.; Paschke, R.; Koch, C. A.: Adrenal incidentaloma diagnosed as pheochromocytoma by serum chromogranin A and plasma metanephrines
61
Haase, M.; Bornstein, S. R.; Paramonova, I.; Schott, M.; Scherbaum, W. A.; Willenberg, H. S.: Expression of CITED2 in human adrenal tissues
62
Dittmar, M.; Schneider, P. M.; Höhler, T.; Wurm, M.; Kahaly, G. J.: MHC class I chain-related antigen A in mono- and polyglandular autoimmunity
63
Parvizi, N.; Mielenz, M.; Dixit, D.: Mechanisms regulating growth hormone secretion from peripheral blood mononuclear cells
64
Morgenthaler, N. G.; Struck, J.; Christ-Crain, M.; Bergmann, A.; Müller, B.: The prohormone of atrial natriuretic peptide (ANP) is elevated in severe sepsis and high levels are associated with poor outcome
65
Bender, G.; Koschker, A. C.; Hahner, S.; Allolio, B.: Is isolated ACTH deficiency associated with a specific autoimmune thyropathy?
66
Untergasser, G.; Plas, E.; Pfister, G.; Berger, P.: Interferon-γ induces neuroendocrine differentiation of in vitro cultivated human prostate basal epithelial cells
67
Tietz, S.; Dittmar, M.; Seissler, J.; Fredenhagen, G.; Weber, M.; Kahaly, G. J.: Antibody profile in families with mono- and polyglandular autoimmunity
68
Schumann, C.; Faust, M.; Gerharz, M.; Ortmann, M.; Schubert, M.; Krone, W.: Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis – a case report
69
Penna-Martinez, M.; Andric, K.; Wahl, R. A.; Usadel, K. H.; Schumm-Draeger, P. M.: Effects of thyrocytes on intrathyroidal HLA-DR+ lymphocytes and CD94+ NK cells in vitro differ depending on thyroid disease
70
Seifarth, C.; Steinlicht, S.; Mack, M.; Harsch, I.; Hahn, E. G.; Lohmann, T.: Transient blockade of chemokine receptors (CCR2, CCR5) does not prevent type 1 diabetes in prediabetic NOD-mice
71
Ramos Lopez, E.; Meyer, G.; Usadel, K. H.; Badenhoop, K.: Vitamin D deficiency and Vitamin D receptor (VDR) genotype in endocrine autoimmune disease
72
Brandenburg, C.; Kosmahl, M.; Mönig, H.; Kloehn, S.: The role of prolactin in the development of liver cirrhosis
73
Maier, C.; Rünzler, D.; Kerschner, H.; Schindelar, J.; Grabner, G.; Köhler, G.; Luger, A.: The membrane glucocorticoid receptor on the pituitary is G protein coupled and interacts with the cytoskeleton
74
Broecker-Preuss, M.; Schmidt, M.; Bollepalli, M.; Baten, J.; Sheu, S. Y.; Schmid, K. W.; Mann, K.: Regulation of thyroid cells and thyroid tumors by the novel cAMP-binding protein Epac
75
Reisch, N.; Slawik, M.; Zwermann, O.; Beuschlein, F.; Reincke, M.: The –2 basepair initiation start site ACTH receptor polymorphism influences ACTH induced adrenal androgen secretion
76
Führer, D.; Eszlinger, M.; Karger, S.; Krause, K.; Dralle, H.; Paschke, R.: Evaluation of ets-1, Cox-2 and IGF-2 as novel diagnostic markers in benign and malignant follicular thyroid neoplasia
77
Michaelis, M.; Schweizer, U.; Sztajer, H.; Köhrle, J.; Schomburg, L.: Tissue-specific growth-defects upon Selenium-deficiency
78
Bidlingmaier, M.; Wu, Z.; Strasburger, C. J.: True total growth hormone (hGH) measurement: Elimination of hGH binding protein (hGHBP) interference by a hGH receptor blocking monoclonal antibody
79
Deppe, U.; Bebermeier, J. H.; Richter Unruh, A.; Wünsch, L.; Körner, I.; Meinicke, E.; Hiort, O.; Holterhus, P. M.: Characterization of the normal scrotal skin fibroblast gene transcription phenotype characterized by large-scale cDNA-microarray analysis
80
Schneider, M. R.; Dahlhoff, M.; Herbach, N.; Renner-Mueller, I.; Wanke, R.; Wolf, E.: Overexpression of betacellulin in transgenic mice results in growth impairment, increased mortility, and multiorgan effects
81
Moerth, C.; Schneider, M. R.; Renner-Müller, I.; Elmlinger, M. W.; Erben, R. G.; Wolf, E.: No rescue of growth deficits by overexpression of IGF-II in IGF-I deficient mice
82
Winkler, A.; Hammje, K.; Finke, R.; Köhrle, J.; Schmutzler, C.; Dralle, H.; Hoang-Vu, C.: Proteome analysis of the follicular thyroid carcinoma cell line FTC-133
83
Schott, M.; Papewalis, C.; Willenberg, H. S.; Schinner, S.; Domberg, J.; Bornstein, S. R.; Scherbaum, W. A.; Seissler, J.: Identification of HLA class II-specific calcitonin epitopes as potential targets for immunotherapy in medullary thyroid carcinoma
84
Labeur, M.; Papazoglou, M.; Theodoropoulou, M.; Stalla, J.; Laupheimer, S.; Paez-Pereda, M.; Arzt, E.; Stalla, G. K.: Retinoic acid and PPAR-γ ligands synergistically inhibit ACTH secretion and proliferation in murine corticotroph tumor cells
85
Minnemann, T.; Fottner, C.; Jennewein, M.; Rösch, F.; Weber, M.: [68Ga] labelled DFO-octreotide is specifically internalized into somatostatin receptor positive AR42J tumor cells at comparable rates to standard [11In] DOTA-DPhe1-Tyr3-octreotide
86
Musholt, T. J.; Weber, M. M.; Fottner, C.; Helisch, A.; Schreckenberger, M.; Musholt, P. B.: Hereditary paraganglioma syndrome PGL-1: diagnostic procedures for localisation of multifocal tumors and surgical strategy in an affected family
87
Hoeflich, A.; Braunreuther, E.; Diehl, D.; Oesterle, D.; Renner-Müller, I.; Göttlicher, M.; Wolf, E.: Tumor-protective effects of IGFBP-2: reduced tumor incidence in IGFBP-2 transgenic mice
88
Petrich, T.; Quintanilla-Fend, L.; Knapp, W. H.; Pötter, E.: Effective cancer therapy by the α-particle emitter [At-211]-astatine in a mouse model of genetically modified NIS-expressing tumors
89
Biering, H.; Brenner, N.; Ventz, M.; Strasburger, C.: Primary neuroendocrine carcinoma of inguinal lymph node
90
Hoffmann, S.; Hofbauer, L.; Wunderlich, A.; Celik, I.; Zielke, A.: The EGF/EGFR system as a possible target for anti tumor therapy in thyroid cancer
91
Pelz, I.; Gall, S.; Sheu, S. Y.; Nokai, B.; Schmid, K. W.; Mann, K.; Broecker-Preuss, M.: Efficacy of erbB specific tyrosine kinase inhibitors in thyroid carcinoma cells
92
Knippert, A.; Czech, N.; Mönig, H.; Fölsch, U.: Jodine-131 metaiodobenzylguanidine (MIBG) treatment for metastatic neuroendocrine tumors of the gastroenteropancreatic tract
93
Hoeflich, A.; Renner, P.; Renner-Müller, I.; Wolf, E.: Elevated life span and altered activities of redox-relevant enzymes in IGFBP-2 transgenic mice
94
Steffin, B.; Gutt, B.; Bidlingmaier, M.; Dieterle, C.; Oltmann, F.; Schopohl, J.: Effects of long acting somatostatin analogues on glucose tolerance and insulin resistance in acromegaly
95
Bergamnn, T.; Völzke, H.; Kuwert, T.; Lohmann, T.; Wallaschofski, H.: Association between serum thyrotropin and high-sensitive CrP as an inflammatory marker of cardiovascular risk
96
Kopf, D.; Gilles, M.; Medlin, F.; Forst, T.; Pfützner, A.; Henn, F.; Lehnert, H.; Deuschle, M.: Effects of the atypical antipsychotic drugs amisulpride and olanzapine on insulin sensitivity and secretion: Glucose clamp studies in healthy volunteers
97
Buettner, R.; Parhofer, K.; Schölmerich, J.; Bollheimer, L. C.: Differential effects of high fat diets on rat glucose and lipid metabolism
98
Harsch, I. A.; Wallaschofski, H.; Pour Schahin, S.; Hahn, E. G.; Koebnick, C.; Lohmann, T.: Resistin in obese patients with obstructive sleep apnea during the courst of CPAP therapy
99
Kreutzer, J.; Eigenthaler, M.; Fahlbusch, R.; Lohmann, T.; Wallaschofski, H.: Association between serum prolactin and high sensitive CrP as an inflammatory marker of cardiovascular risk
100
Siegmund, T.; Schumm-Draeger, P. M.: Carbohydrate adjusted preprandial insulin doses are supperior to fixed carbohydrate independant insulin doses in slightly overweight people with type 2 diabetes. An evaluation using a Continuous Glucose Monitoring System (CGMS) in addition to Self Monitored Blood Glucose (SMBG)
101
Osterhoff, M. A.; Herrmann, M.; Lazdins, M.; Kaiser, S.; Assert, R.; Weickert, M. O.; Spranger, J.; Möhlig, M.; Pfeiffer, A. F. H.: Association of two genetic markers within the protein kinase C beta gene with type 2 diabetes mellitus
102
Möhlig, M.; Klonower, C.; Spranger, J.; Osterhoff, M.; Ristow, M.; Pfeiffer, A. F.: PPARγ Pro12Ala polymorphism not associated with metabolic syndrome in a German cohort
103
Andres, J.; Diederich, S.; Pfeiffer, A.; Bähr, V.: Mutation of 11beta-hydroxysteroid dehydrogenase type 1 to express soluble protein for structural analysis in the search of a selective enzyme inhibitor
104
Kreutzer, J.; Schmidt, V.; Blümcke, I.; Fahlbusch, R.; Buslei, R.: Mutational analysis of TOK-1 in pituitary adenomas
105
Lemke, U.; Künstlin, V.; Herzig, S.: Transcriptional repressor HES-1– a critical check-point in hepatic lipid homeostasis
106
Fröhlich, E.; Macchicao, F.; Wahl, R.: Effect of retinoids, histondeacetylase inhibitors and glitazones on the differentiation of cultured transformed thyrocytes
107
Krätzner, R.; Schinner, S.; Schlenczeck, S.; Dickel, C.; Knepel, W.: Effect of rosiglitazone and PPARγ on insulin gene transcription and mapping of PPARγ domains involved in insulin/glucagon gene transcriptional regulation
108
Ramos Lopez, E.; Herwig, J.; Usadel, K. H.; Badenhoop, K.: A novel polymorphism within the vitamin D receptor (VDR) is associated with type 1 diabetes mellitus in Germans
109
Krones-Herzig, A.; Metzger, D.; Ziegler, A.; Herzig, S.: Nuclear receptor co-factor RIP140, a new candidate gene for type II diabetes susceptibility
110
Ueberberg, B.; Tourné, H.; Unger, N.; Redmann, A.; Mann, K.; Petersenn, S.: Transcriptional regulation of the human somatostatin receptor subtypes (sst 1–5) in adrenal cortex and medulla cells
111
Gründker, C.; Günthert, A. R.; Hellriegel, M.; Emons, G.: Gonadotropin-Releasing Hormone (GnRH) agonist triptorelin inhibits estradiol-induced Serum Response Element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells
112
Rothhammer, V.; Päth, G.; Kassem, M.; Brendel, M. D.; Bretzel, R. G.; Seufert, J.: p8 overexpression enhances proliferation and growth of adult human hMSC-TERT stem cells
113
Briese, J.; Sudahl, S.; Schulte, H. M.; Löning, T.; Bamberger, A. M.: Expression pattern of the AP-1 family of transcription factors in Gestational Trophoblastic Diseases (GTD)
114
Neulen, J.; Berghaus, D.; Grümmer, R.; Weich, H.; Motejlek, K.: Modulation of sVEGFR-1 secretion by follicular fluid
115
Haag, C.; Varma, C.; Hentze, S.; Schulze, E.; Raue, F.: A novel splice site mutation in the SDH-B gene in familial paragangliomas
116
Seidlová-Wuttke, D.; Moneke, K.; Mäkelä, S.; Gustafsson, J. A.; Wuttke, W.: Functions of estradiol in the urinary bladder
117
Wober, J.; Krumbholz, M.; Vollmer, G.: Effects of Cimicifuga racemosa extracts on estrogen responsive genes in rat pituitary gland in vitro and in vivo
118
Henke, A.; Gromoll, J.; Simoni, M.: Expression of chorionic gonadotropin in the pituitary of the common marmoset (Callithrix jacchus)
119
Tonack, S.; Rolletschek, A.; Wobus, A. M.; Fischer, B.; Navarrete Santos, A.: Differential expression of glucose transporter isoforms during ES cell differentiation in vitro
120
Luetjens, C. M.; Kuhlmann, M.; Wesselmann, R.: Down regulation of the estrous cycle in marmoset monkeys by GnRH-antagonist treatment
121
Tan, S.; Hahn, S.; Pleger, K.; Sack, S.; Herrmann, B. L.; Mann, K.; Janssen, O. E.: Cardiovascular risk factors in polycystic ovary syndrome
122
Hahn, S.; Haselhorst, U.; Schütz, A.; Tan, S.; Herrmann, B. L.; Quadbeck, B.; Mann, K.; Janßen, O. E.: Leptin and soluble leptin receptor levels in patients with the polycystic ovary syndrome: influence of metabolic and endocrine parameters
123
Hahn, S.; Elsenbruch, S.; Balamitsa, E.; Pleger, K.; Benson, S.; Tan, S.; Mann, K.; Janssen, O. E.: Impact of clinical and biochemical parameters on quality of life and sexuality in PCOS
124
Mattle, V.; Bilgyicildirim, A.; Leyendecker, G.; Wildt, L.: Hyperandrogenemic-hypothalamic ovarian insufficiency – a new disease entity
125
Quinkler, M.; Cooper, M. S.; Kaur, K.; Arlt, W.; Stewart, P. M.; Hewison, M.: Progesterone inactivation in human osteoblasts
126
Rondot, S.; Haag, C.; Frank-Raue, K.; Schulze, E.; Raue, F.: Analysis of polymorphisms in the MEN 1 gene and Calcium sensing receptor gene in sporadic primary hyperparathyroidism
127
Gimm, O.; Nguyen Thanh, P.; Bloching, M.; Lorenz, K.; Howell, V.; Marsh, D.; Dralle, H.: Hyperparathyroidism-jaw tumor (HPT-JT)-syndrome: three case reports
128
Giesen, M.; Ponce, M. L.; Viereck, V.; Hennies, B.; Hüfner, M.; Siggelkow, H.: Expression of transcription factors Osterix and Core binding factor alpha1 in two differentiating models of primary human osteoblasts in culture
129
Seidlová-Wuttke, D.; Stolze, M.; Vossmann, V.; Wuttke, W.: Effects of 3 estrogenic UV filters on bone in ovariectomized rats
130
Pfützner, A.; Tillmann, H. C.; Abdollhania, R.; Nguyen, M.; Meyer, M.; Forssmann, W. G.; Forssmann, U.; Forst, T.: Pharmacokinetic and pharmacodynamic characteristics of subcutaneously applied PTH-1–37
131
Falk, S.; Kratzsch, J.; Paschke, R.; Stumvoll, M.; Koch, C. A.: Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D
132
Blind, E.; Meyer, S.; Hahner, S.; Allolio, B.; Heindel, U.: Translocation of beta-arrestin2 by the PTH type 2 receptor is independent from its ligand-induced cAMP signaling, phospholipase C-dependent signaling, or MAP kinase signaling
133
Hertrampf, T.; Ait Kaid Rabi, A. J.; Degen, G.; Di Virgilio, A. L.; Laudenbach-Leschowski, U.; Diel, P.: Effects of 17β-estradiol and isoflavones on movement drive, body weight, and bone density in ovariectomised female rats
134
Streckfuß, F.; Schweizer, U.; Schomburg, L.; Köhrle, J.: A novel mouse model to study the importance of the liver for thyroid hormone metabolism
135
Führer, D.; Clauss, M.; Kujat, C.; Paschke, R.: Familial non-autoimmune hyperthyroidism due to a novel TSHR germline mutation (Ile568Val)
136
Geffers, L.; Bauer, K.: Generation and analysis of thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) deficient mice
137
Karger, S.; Engelhardt, C.; Herrmann, F.; Müller, P.; Schmidt, H. T.; Weiss, C. L.; Dralle, H.; Lippitsch, M.; Tannapfel, A.; Paschke, R.; Führer, D.: Cytology and mRNA expression analysis of fine needle aspirates of nodular thyroid disease
138
Hamann, I.; Hofmann, P.; Schmutzler, C.; Mentrup, B.; Huhne, K.; Jarry, H.; Seidlová-Wuttke, D.; Wuttke, W.; Köhrle, J.: 4MBC and OMC, components of UV-sunscreens, exert organ specific alterations on type I 5'-Deiodinase activity and expression in female rats
139
Trojanowicz, B.; Winkler, A.; Hammje, K.; Chen, Z.; Sekulla, C.; Glanz, D.; Schmutzler, C.; Mentrup, B.; Hombach-Klonisch, S.; Klonisch, T.; Finke, R.; Köhrle, J.; Dralle, H.; Hoang-Vu, C.: Influence of retinoic acid on post-translational modifications of a-enolase in the human follicular thyroid carcinoma cell line FTC-133
140
Krohn, K.; Paschke, R.: Frequent polyclonal origin of micro-dissected thyroid follicles in normal but not in nodular thyroid tissue
141
Dörr, M.; John, U.; Wallaschofski, H.; Felix, S. B.; Völzke, H.: Low serum thyrotropin is associated with high plasma fibrinogen levels. The Study of Health in Pomerania
142
Kleinhardt, M.; Nicula, D.; Thomas, T.; Brabant, G.; Derwahl, M.: Thyroid dysfunctions and metabolic changes in centenarians: consequence or cause of longevity?
143
Moeller, L. C.; Dumitrescu, A. M.; Walker, R. L.; Meltzer, P. S.; Refetoff, S.: Identification of thyroid hormone target genes in human cells
144
Kleinemeier, E.; Hampel, E.; Hiort, O.; Thyen, U.: Clinical outcome research in intersexuality – prospects of network funding by the Federal Ministry of Education and Research (BMBF)
145
Haag, C.; Schulze, E.; Raue, F.: Detection of deletions of the SHOX gene in patients with LWD, ISS and Turner Syndrome
146
Richter-Unruh, A.; Schmittmann-Ohters, K.; Hauffa, B. P.: Can heterozygous intron mutations in the Luteinizing Hormone receptor gene cause delayed puberty?
147
Remer, T.; Fonteyn, N.; Alexy, U.: Iodine status in schoolchildren between 1996 and 2003: longitudinal 24-h urinary iodine excretion in 6–12 years old participants of the DONALD study
148
Schneider, H. J.; Pickel, J.; Poland, D.; Schaaf, L.; Stalla, G. K.: Sexually dimorphic features in transsexuals – a female 2nd to 4th finger (2D/4D) ratio in male-to-female transsexuals
149
Binder, G.; Kanther, I.; Schwarze, C. P.; Ranke, M. B.: Cholestasis in neonates with congenital combined pituitary hormone deficiency: there is etiology besides endocrinology
150
Völkl, T. M. K.; Simm, D.; Schwöbel, K.; Beier, C.; Rohrer, T. R.; Dörr, H. G.: Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for Gestational Age (SGA)
151
Unger, N.; Hauffa, B. P.; Mann, K.; Petersenn, S.: Re-evaluation of the somatotropic axis in patients with childhood-onset GH deficiency during transition to adulthood
152
Hoppe, U.; Holterhus, P. M.; Wünsch, L.; Drechsler, T.; Smrcek, J.; Marschke, C.; Hiort, O.: Key-enzymes of human sexual differentiation show tissue specific transcription profiles
153
Gutt, B.; Steffin, B.; Bidlingmaier, M.; Goodwin, L.; Schopohl, J.: Endogenous GH levels after growth hormone receptor antagonist treatment with and without additional Octreotide
154
Onofri, C.; Theodoropoulou, M.; Losa, M.; Lange, M.; Uhl, E.; Stalla, G. K.; Renner, U.: Expression of VEGF receptors in normal and adenomatous human pituitary
155
Mittag, J.; Heuer, H.; Friedrichsen, S.; Visser, T.; Bauer, K.: Deiodinase type II is regulated by TRα1 and expressed in pituitary thyrotrophs
156
Schubert, S.; Achenbach, H.; Engelmann, L.; Borte, G.; Stumvoll, M.; Koch, C. A.: Central diabetes insipidus and secondary adrenal insufficiency as a complication of Malaria tropica
157
Flitsch, J.; Lüdecke, D.; Saeger, W.; Westphal, M.: Dedifferentiation of a growth-hormone secreting pituitary adenoma to a non-secreting carcinoma
158
Trantakis, C.; Koch, C.; Tannapfel, A.; Meixensberger, J.; Drynda, K.; Führer, D.: Acromegaly caused by a thoracic neuroendocrine tumor
159
Jarry, H.; Schlecht, C.; Klammer, H.; Wuttke, W.: Effects of the putative xenoestrogens Benzophenone-2 (BP2) and Octyl-methoxycinnamate (OMC) on gene expression in the rat pituitary
160
Zitzmann, K.; Vlotides, G.; Auernhammer, C. J.: Characterization of the promoter region of murine NNT-1/BSF-3– a novel paracrine modulator of corticotroph function
161
Deutschbein, T.; Unger, N.; Wiedemayer, H.; Stolke, D.; Yuece, A.; Mann, K.; Petersenn, S.: Diagnosis of secondary adrenal insufficiency: evaluation of the standard dose short synacthen test in comparison to the insulin tolerance test in patients with hypothalamic-pituitary disease
162
Joseph, F.; Brabant, G.; Ahmad, A.; Fraser, W.; Vora, J.: The effect of growth hormone replacement in adult growth hormone deficiency on the diurnal and ultradian dynamics of ghrelin, leptin, soluble leptin receptor and adiponectin
163
Reschke, K.; Schulz, C.; Peters, B.; Riech, C.; Lehnert, H.: Adiponectin and ghrelin levels in craniopharyngioma patients
164
Quadbeck, B.; Hoermann, R.; Hahn, S.; Roggenbuck, U.; Mann, K.; Janssen, O. E.: Sensitive TSH and TSH-receptor antibody determinations as predictors of relapse in Graves' disease
165
Broecker-Preuss, M.; Sheu, S. Y.; Kosti, K.; Janssen, O. E.; Schmid, K. W.; Mann, K.; Herrmann, B. L.: Expression of IGF-1 receptors and GH receptors in thyroid tissue of patients with acromegaly
166
Musholt, T. J.; Musholt, P. B.: Surgical intervention for Graves' disease: a plea for total thyroidectomy
167
Schott, M.; Minich, W. B.; Papewalis, C.; Seissler, J.; Scherbaum, W. A.; Morgenthaler, N. G.: Relevance of TSH-Receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease
168
Mineva, I.; Gartner, W.; Hauser, P.; Kainz, A.; Löffler, M.; Wolf, G.; Oberbauer, R.; Niederle, B.; Weissel, M.; Wagner, L.: AlphaB-crystallin expression in various endocrine neoplasias and identification of underlying mechanisms leading to alphaB-crystallin gene silencing in de-differentiated thyroid tumors
169
Pyka, J.; Glogowska, A.; Hoang-Vu, C.; Klonisch, T.: Enhanced microtubular stability correlates with lower proliferation and cell motility in stable FTC-133 overexpressing the cytoplasmic domain of epidermal growth factor (proEGFcyt)
170
Eckstein, A.; Plicht, M.; Lax, H.; Quadbeck, B.; Mann, K.; Esser, J.; Morgenthaler, N. G.: TSH-Receptor autoantibodies help to predict severity and outcome of Graves' ophthalmopathy
171
Frank-Raue, K.; Buhr, H.; Dralle, H.; Klar, E.; Senninger, N.; Weber, T.; Rondot, S.; Höppner, W.; Raue, F.: Follow-up in 41 multiple endocrine neoplasia type 2 A (MEN 2A) gene carriers after prophylactic thyroidectomy – problems with thyroxine substitution
172
Lobmann, R.; Zacheja, S.; Mühlen, I.; Lehnert, H.: The expression of Metalloproteinases (MMP) mRNA in an ex-vivo model of keratinocytes is not different between diabetic patients and non-diabetic controls
173
Deuß, U.; Kaulen, D.; Faust, M.: Long-term treatment of acromegaly with octreotide: a case report
174
Kuehnert, B.; Byrne, M.; Koepcke, W.; Gerss, J.; Lemmnitz, G.; Nieschlag, E.: Scrotal application and early removal of a new hydroalcoholic testosterone gel is an efficacious alternative for testosterone substitution: Results of a controlled, multicenter trial
175
Wunsch, A.; Ahda, Y.; Gromoll, J.; Asatiani, K.; Nieschlag, E.; Simoni, M.: Single nucleotide polymorphisms in the promoter and coding region of the FSH receptor gene determine four haplotypes differently distributed in normozoospermic and azoospermic men
176
Jacobeit, J. W.; Groß, U. S.; Drexler, H. H.; Ludwig, M.; Schulte, H. M.: Improvement of fertility in men with adrenal enzyme deficencies
177
Bliesener, N.; Albrecht, S.; Weckbecker, K.; Schwager, A.; Lichtermann, D.; Klingmüller, D.: Plasma testosterone, Inhibin B and sexual function in men on methadone or buprenorphine maintenance for opioid dependence
178
Heydecke, D.; Meyer, D.; Gudermann, T.; Boekhoff, I.: The PDZ-domaine protein MUPP1 is expressed in spermatozoa of vertebrates
179
Haider, S. G.; Hardy, M.; Blanchard, R.; Blanchard, D.; Epal, T.: Changes in 3beta-HSD, 11beta-HSD type 1, and apoptotic proteins in rat testis induced by psychosocial stress
180
Loeper, S.; Jung, R.; Bubenheim, M.; Bamberger, C. M.: Direct suppression of testosterone secretion by single ultra high dose glucocorticoid administration
181
Pühse, G.; Secker, A.; Kemper, S.; Hertle, L.; Kliesch, S.: Early androgen deficiency in testicular germ cell cancer patients
182
Berthold, I.; Naini, A.; di Mauro, S.; Krone, W.; Berthold, H. K.: The effect of ezetimibe and simvastatin on coenzyme Q10 levels in healthy men
183
Wistuba, J.; Junaidi, A.; Luetjens, C.; Kamischke, A.; Yeung, C. H.; Simoni, M.; Nieschlag, E.: Norethisterone enanthate has neither direct effect on the testis nor on the epididymis: A study in adult male cynomolgus monkeys (Macaca fascicularis)